More evidence for shortening antibiotic therapy in peritonitis: the DURAPOP trial

Hira H. Abidi, Robert G. Sawyer


Recently, Montravers et al. published the DURAPOP randomised clinical trial of duration of antimicrobial therapy for patients treated in the intensive care unit (ICU) for post-operative peritonitis (1). The investigators should be lauded for a carefully conceived and executed trial in a very challenging and sick patient population